Cristina Martínez Miró

Predictors of clinically significant quality of life impairment in Parkinson’s disease

Diego Santos‐García, Teresa de Deus Fonticoba, Carlos Cores et al. · npj Parkinson s Disease · 2021 · 42 citations · Full text

Pharmacy, Neurology, Neuroscience +17

Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study

Diego Santos‐García, Carmen M. Labandeira, Rosa Yáñez Baña et al. · Brain Sciences · 2021 · 37 citations · Full text

Medicine, Neurology, Pharmacotherapy +15

Safinamide improves sleep and daytime sleepiness in Parkinson’s disease: results from the SAFINONMOTOR study

Diego Santos‐García, Carmen M. Labandeira, Rosa Yáñez Baña et al. · Neurological Sciences · 2021 · 23 citations · Full text

Medicine, Neurology, Pharmacology +16

Pain Improvement in Parkinson’s Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR Study

Diego Santos‐García, Rosa Yáñez Baña, Carmen M. Labandeira et al. · Journal of Personalized Medicine · 2021 · 21 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson's disease patients

Diego Santos‐García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé et al. · International Journal of Geriatric Psychiatry · 2022 · 20 citations · Full text

Medicine, Neurology, Behavioral Health +16